Next Article in Journal
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
Next Article in Special Issue
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
Previous Article in Journal
Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles
Previous Article in Special Issue
Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery

Delivery of Cancer Therapeutics Using Nanotechnology

Department of Radiology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea
Department of Chemical and Biomolecular Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea
Department of Chemistry, Korea University, 145 Anam-ro, Dongdaemun-gu, Seoul 136-701, Korea
Authors to whom correspondence should be addressed.
Pharmaceutics 2013, 5(2), 294-317;
Received: 24 December 2012 / Revised: 15 April 2013 / Accepted: 3 May 2013 / Published: 15 May 2013
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems. View Full-Text
Keywords: nanoparticles; nanotechnology; drug delivery; cancer; theranostic nanoparticles nanoparticles; nanotechnology; drug delivery; cancer; theranostic nanoparticles
Show Figures

Figure 1

MDPI and ACS Style

Lim, E.-K.; Jang, E.; Lee, K.; Haam, S.; Huh, Y.-M. Delivery of Cancer Therapeutics Using Nanotechnology. Pharmaceutics 2013, 5, 294-317.

AMA Style

Lim E-K, Jang E, Lee K, Haam S, Huh Y-M. Delivery of Cancer Therapeutics Using Nanotechnology. Pharmaceutics. 2013; 5(2):294-317.

Chicago/Turabian Style

Lim, Eun-Kyung, Eunji Jang, Kwangyeol Lee, Seungjoo Haam, and Yong-Min Huh. 2013. "Delivery of Cancer Therapeutics Using Nanotechnology" Pharmaceutics 5, no. 2: 294-317.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop